Suesskind Dan S
Known title: DirectorCIK: 0001303873
Suesskind Dan S's purchase track record
Suesskind Dan S has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/14/2026 | NNOX | $45K | pending | pending | — |
| 7/27/2026 | NNOX | $47K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NNOX | ▲ Buy | Open Market | 30,000 | $23K | 9/14/2026 | View on chart |
| NNOX | ▲ Buy | Open Market | 30,000 | $23K | 9/14/2026 | View on chart |
| NNOX | ▲ Buy | Open Market | 25,000 | $24K | 7/27/2026 | View on chart |
| NNOX | ▲ Buy | Open Market | 25,000 | $23K | 7/27/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nanox Expands 3D Imaging Access
Nano-X Imaging is expanding access to its 3D imaging and diagnostics through an integrated ecosystem. This move aims to broaden the reach of its technology in the medical field. The company remains a high-beta stock, with the current price near its 52-week low of $0.63.
Nanox Expands 3D Imaging Access. Nano-X Imaging is expanding access to its 3D imaging and diagnostics through an integrated ecosystem. This move aims to broaden the reach of its technology in the medical field. The company remains a high-beta stock, with the current price near its 52-week low of $0.63.